Board Moves.

Cardinal Health (NYSE: CAH)

Appoints Robert Musslewhite and Sudhakar Ramakrishna to the Board of Directors. Mr. Musslewhite is the former Chief Executive Officer at Definitive Healthcare and Mr. Ramakrishna is the Chief Executive Officer at SolarWinds.

Collegium Pharmaceutical (NASDAQ: COLL)

Appoints Carlos Paya to the Board of Directors. Mr. Paya is a Partner at Abingworth.

Contineum Therapeutics (NASDAQ: CTNM)

Appoints Diego Miralles to the Board of Directors. Mr. Miralles is the former Chief Executive Officer at AZURNA Therapeutics.

DexCom (NASDAQ: DXCM)

Appoints Renee Gala to the Board of Directors. Ms. Gala is the President and Chief Operating Officer at Jazz Pharmaceuticals.

Dianthus Therapeutics (NASDAQ: DNTH)

Appoints Sujay Kango to the Board of Directors. Mr. Kango is the former President and Chief Executive Officer at Tmunity Therapeutics Incorporated.

Fortrea (NASDAQ: FTRE)

Appoints Erin Russell to the Board of Directors. Ms. Russell is a former Principal at Vestar Capital Partners.

Immunocore plc (NASDAQ: IMCR)

Appoints William Pao to the Board of Directors. Mr. Pao is the Co-Founder and Chief Executive Officer at Revelio Therapeutics.

Lifestance Health Grp (NASDAQ: LFST)

Promotes David Bourdon to CEO and he is appointed to the Board of Directors. Mr. Bourdon is the former Chief Financial Officer at Magellan Health.

Madrigal Pharmaceuticals (NASDAQ: MDGL)

Appoints Jackie Fouse to the Board of Directors. Ms. Fouse is the former Chief Executive Officer at Agios Pharmaceuticals.

Natera (NASDAQ: NTRA)

Appoints Monica Bertagnolli to the Board of Directors. Ms. Bertagnolli is the Professor of Surgery at Harvard Medical School and Associate Surgeon in the Division of Surgical Oncology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute.

National Research (NASDAQ: NRC)

Names Trent Green CEO and he is appointed to the Board of Directors. Mr. Green is the former Chief Executive Officer at Amazon One Medical.

National Vision (NASDAQ: EYE)

Appoints James McGrann and Michael Nicholson to the Board of Directors. Mr. McGrann is the Chief Executive Officer at Advancing Eyecare and Mr. Nicholson is the former Chief Operating Officer at JCrew Group.

Nurix Therapeutics (NASDAQ: NRIX)

Appoints Roy Baynes to the Board of Directors. Mr. Baynes is the Chief Medical Officer at Eikon Therapeutics.

‍

‍

‍

Elanco Animal Health (NYSE: ELAN)

William Doyle, John Bilbrey, Kathy Turner and Craig Wallace to leave the Board of Directors. Mr. Doyle is the Executive Chair of the Board at Novocure Ltd, Mr. Bilbrey is the former CEO at Hershey, Ms. Turner is the Chief Marketing Officer at IDEXX and Mr. Wallace is a President at Wallace Investments.

Integer (NYSE: ITGR)

William Summers to leave the Board of Directors. Mr. Summers is the former Chief Executive Officer at McDonald Investments.

Kymera Therapeutics (NASDAQ: KYMR)

Leigh Morgan to leave the Board of Directors. Ms. Morgan is the Chief Executive Officer at Imaginal Leadership Strategies.

Ocean Biomedical (NASDAQ: OCEA)

Amy Griffith to leave the Board of Directors. Mr. Griffith is the Vice President of Government Relations at CGI.